Literature DB >> 26897485

Pathobiology of Ischemic Heart Disease: Past, Present and Future.

L Maximilian Buja1, Richard S Vander Heide2.   

Abstract

This review provides a perspective on knowledge of ischemic heart disease (IHD) obtained from the contemporary era of research which began in the 1960s and has continued to the present day. Important discoveries have been made by basic and translational scientists and clinicians. Pathologists have contributed significantly to insights obtained from experimental studies and clinicopathological studies in humans. The review also provides a perspective for future directions in research in IHD aimed at increasing basic knowledge and developing additional therapeutic options for patients with IHD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hibernation; Mitochondria; Myocardial infarction; Myocardial ischemia; Postconditioning; Preconditioning; Stunning

Mesh:

Year:  2016        PMID: 26897485     DOI: 10.1016/j.carpath.2016.01.007

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  13 in total

1.  Diagnosis of myocardial ischemia combining multiphase postmortem CT-angiography, histology, and postmortem biochemistry.

Authors:  Jessica Vanhaebost; Kewin Ducrot; Sébastien de Froidmont; Maria Pia Scarpelli; Coraline Egger; Pia Baumann; Gregory Schmit; Silke Grabherr; Cristian Palmiere
Journal:  Radiol Med       Date:  2016-10-20       Impact factor: 3.469

2.  Tyrosine nitration of mitochondrial proteins during myocardial ischemia and reperfusion.

Authors:  Zuzana Tatarkova; Maria Kovalska; Monika Kmetova Sivonova; Peter Racay; Jan Lehotsky; Peter Kaplan
Journal:  J Physiol Biochem       Date:  2019-05-21       Impact factor: 4.158

3.  Development of a nanomedicine-loaded hydrogel for sustained delivery of an angiogenic growth factor to the ischaemic myocardium.

Authors:  Joanne O'Dwyer; Robert Murphy; Eimear B Dolan; Lenka Kovarova; Martin Pravda; Vladimir Velebny; Andreas Heise; Garry P Duffy; Sally Ann Cryan
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

4.  Abrogation of CC chemokine receptor 9 ameliorates ventricular remodeling in mice after myocardial infarction.

Authors:  Yan Huang; Dandan Wang; Xin Wang; Yijie Zhang; Tao Liu; Yuting Chen; Yanhong Tang; Teng Wang; Dan Hu; Congxin Huang
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

5.  Capsaicin Protects Cardiomyocytes against Anoxia/Reoxygenation Injury via Preventing Mitochondrial Dysfunction Mediated by SIRT1.

Authors:  Huan He; Yue Zhou; Jiyi Huang; Zelong Wu; Zhangping Liao; Dan Liu; Dong Yin; Ming He
Journal:  Oxid Med Cell Longev       Date:  2017-12-24       Impact factor: 6.543

Review 6.  Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases.

Authors:  Lili Wang; Rufeng Ma; Chenyue Liu; Haixia Liu; Ruyuan Zhu; Shuzhen Guo; Minke Tang; Yu Li; Jianzhao Niu; Min Fu; Sihua Gao; Dongwei Zhang
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 7.  The Importance of the Autopsy in Medicine: Perspectives of Pathology Colleagues.

Authors:  Louis Maximilian Buja; Rolf F Barth; Gerhard R Krueger; Sergey V Brodsky; Robert L Hunter
Journal:  Acad Pathol       Date:  2019-03-10

Review 8.  The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: Revisited.

Authors:  Gino A Kurian; Rashmi Rajagopal; Srinivasan Vedantham; Mohanraj Rajesh
Journal:  Oxid Med Cell Longev       Date:  2016-05-25       Impact factor: 6.543

9.  Salvianolic Acid B-Alleviated Angiotensin II Induces Cardiac Fibrosis by Suppressing NF-κB Pathway In Vitro.

Authors:  Chunhua Wang; Hong Luo; Yini Xu; Ling Tao; Churui Chang; Xiangchun Shen
Journal:  Med Sci Monit       Date:  2018-10-26

Review 10.  Mitochondrial Quality Control: Role in Cardiac Models of Lethal Ischemia-Reperfusion Injury.

Authors:  Andrew R Kulek; Anthony Anzell; Joseph M Wider; Thomas H Sanderson; Karin Przyklenk
Journal:  Cells       Date:  2020-01-15       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.